Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naïve cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study

Audrey Giocanti-Aurégan; Chang-Hao Yang; Simone Donati; Helmut Allmeier; Tobias Machewitz; Kay D. Rittenhouse; Hans Hoerauf

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1762.

ARVO Annual Meeting Abstract June 2023

Intravitreal aflibercept in routine clinical practice: 24-month results from the global cohort of pretreated patients with diabetic macular edema in the AURIGA study

Simone Donati; Marco Mura; Audrey Giocanti-Aurégan; Hans Hoerauf; Chang-Hao Yang; Helmut Allmeier; Tobias Machewitz; Elina Santoro

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2637.

ARVO Annual Meeting Abstract July 2019

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

Jean-Francois Korobelnik; Laurent Kodjikian; Vincent Daien; Celine Faure; Ramin Tadayoni; Audrey Giocanti-Aurégan; Pascale Massin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3651.

ARVO Annual Meeting Abstract July 2018

Ethnical differences in normal retinal capillary density and foveal avascular zone measurements

Audrey Giocanti Auregan; Gaspard Gazeau; Linda Hrarat; Vincent Lévy; Franck Fajnkuchen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2859.

ARVO Annual Meeting Abstract July 2018

Efficacy and safety of aflibercept in diabetic macular edema: real life study

Linda Hrarat; Audrey Giocanti Auregan; Sylvia Buffet; Franck Fajnkuchen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4822.

ARVO Annual Meeting Abstract July 2018

Value of a dry retina during DME treatment by ranibizumab: sub-Analysis of RESTORE, REVEAL, RESPOND and RETAIN studies

Franck Fajnkuchen; Philippe Margaron; Jonathan Wright; Audrey Giocanti Auregan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3619.

ARVO Annual Meeting Abstract June 2017

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab and/or intravitreal dexamethasone implant

Antoine Herbaut; Lise Qu Knafo; Audrey Giocanti Auregan; Franck Fajnkuchen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1891.

ARVO Annual Meeting Abstract June 2017

Differential effect of corticosteroids on Müller glial cells

Audrey Giocanti Auregan; Lourdes Siqueiros-Marquez; Hugo Charles-Messance; Romain Bénard; Cecilia Montañez; José Alain sahel; Florian Sennlaub; Xavier Guilloneau; Bahram Bodaghi; Ramin Tadayoni; Alvaro Rendon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5393.

Letters to the Editor March 2017

Author Response: Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab

PDF

Audrey Giocanti-Auregan; Franck Fajnkuchen
TAGS: diabetic macular edema, exudative retinal detachment, ranibizumab
Invest. Ophthalmol. Vis. Sci.. 2017; 58(3):1857. https://doi.org/10.1167/iovs.17-21726

New Developments in Vision Research February 2017

Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood–Retinal Barrier Breakdown

PDF

Lourdes Siqueiros-Marquez; Romain Bénard; Ophélie Vacca; Hugo Charles-Messance; Rodrigo Bolaños-Jimenez; Xavier Guilloneau; Florian Sennlaub; Cecilia Montañez; José Alain Sahel; Alvaro Rendon; Ramin Tadayoni; Audrey Giocanti-Aurégan
TAGS: dexamethasone, mice, surgical procedures, operative, lens (device), surgery specialty, blood-retinal barrier, lens, crystalline, retina, down-regulation
Invest. Ophthalmol. Vis. Sci.. 2017; 58(2):876-886. https://doi.org/10.1167/iovs.16-20617

Includes: Supplemental Content

Retina February 2017

Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab

PDF

Audrey Giocanti-Aurégan; Linda Hrarat; Lise M. Qu; Valérie Sarda; Marouane Boubaya; Vincent Levy; Gilles Chaine; Franck Fajnkuchen
TAGS: diabetic macular edema, exudative retinal detachment, ranibizumab
Invest. Ophthalmol. Vis. Sci.. 2017; 58(2):797-800. https://doi.org/10.1167/iovs.16-20855

Retina December 2015

Predictive Value of Outer Retina En Face OCT Imaging for Geographic Atrophy Progression

PDF

Audrey Giocanti-Auregan; Ramin Tadayoni; Franck Fajnkuchen; Pauline Dourmad; Stéphanie Magazzeni; Salomon Y. Cohen
TAGS: atrophy, diagnostic imaging, face, predictive value, retina, hypertrophy
Invest. Ophthalmol. Vis. Sci.. 2015; 56(13):8325-8330. https://doi.org/10.1167/iovs.14-15480

ARVO Annual Meeting Abstract June 2015

Impact of serous retinal detachment on the efficacy of ranibizumab therapy in diabetic macular edema

Franck Fajnkuchen; Lise Qu; Valerie Sarda; Gilles Chaine; Audrey Giocanti-Auregan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1756.

ARVO Annual Meeting Abstract April 2014

Predictive value of outer retina Enface OCT imaging in geographic atrophy progression

Audrey Giocanti-Auregan; Pauline Dourmad; Ramin Tadayoni; Stephanie Magazzeni; Salomon Y Cohen

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1240.

ARVO Annual Meeting Abstract April 2014

Impact of summer follow-up interruption on functional and anatomical results over the course of Ranibizumab treatment for Diabetic Macular Edema

ora levy; Franck Fajnkuchen; Benjamin Penaud; Gilles Chaine; Audrey Giocanti-Auregan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1774.

ARVO Annual Meeting Abstract April 2014

Complete retinal fluid resorption with low visual acuity in patients with diabetic macular edema (DME) over the course of ranibizumab treatment: Optical Coherence Tomography (OCT) analysis

Benjamin Penaud; Audrey Giocanti-Auregan; Ora Levy; Gilles Chaine; Franck Fajnkuchen

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1786.

ARVO Annual Meeting Abstract April 2014

Impact of lens thickness on hyper mature cataract surgical complications: preliminary results of a prospective study

Addou Regnard Manar; Franck Fajnkuchen; Anh Bui; Gilles Chaine; Audrey Giocanti-Auregan; Bobigny

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2813.

ARVO Annual Meeting Abstract June 2013

Profiling miRNAs in a hyperglycemic and hypoinsulinemic Ins2Akita mouse model

Audrey Giocanti-Auregan; Lisa Ahn; Javier Sancho-Pelluz; Stephen Tsang; Szilard Kiss; Mark Rosenblatt; Thomas Tuschl; John Pena; Donald D’Amico

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):273.

ARVO Annual Meeting Abstract March 2012

Selective Laser Trabeculoplasty: 12 Years Follow Up

Audrey Giocanti-Auregan; Yves Lachkar

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5968.

ARVO Annual Meeting Abstract April 2011

A New Quantifiable Blood Retinal Barrier Breakdown Model In Mice

Romain Benard; Audrey Giocanti-Auregan; Brahim El-Mathari; Ophélie Vacca; José-Alain Sahel; Alvaro Rendon; Ramin Tadayoni

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4518.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naïve cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study

Intravitreal aflibercept in routine clinical practice: 24-month results from the global cohort of pretreated patients with diabetic macular edema in the AURIGA study

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

Ethnical differences in normal retinal capillary density and foveal avascular zone measurements

Efficacy and safety of aflibercept in diabetic macular edema: real life study

Value of a dry retina during DME treatment by ranibizumab: sub-Analysis of RESTORE, REVEAL, RESPOND and RETAIN studies

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab and/or intravitreal dexamethasone implant

Differential effect of corticosteroids on Müller glial cells

Author Response: Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab

Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood–Retinal Barrier Breakdown

Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab

Predictive Value of Outer Retina En Face OCT Imaging for Geographic Atrophy Progression

Impact of serous retinal detachment on the efficacy of ranibizumab therapy in diabetic macular edema

Predictive value of outer retina Enface OCT imaging in geographic atrophy progression

Impact of summer follow-up interruption on functional and anatomical results over the course of Ranibizumab treatment for Diabetic Macular Edema

Complete retinal fluid resorption with low visual acuity in patients with diabetic macular edema (DME) over the course of ranibizumab treatment: Optical Coherence Tomography (OCT) analysis

Impact of lens thickness on hyper mature cataract surgical complications: preliminary results of a prospective study

Profiling miRNAs in a hyperglycemic and hypoinsulinemic Ins2Akita mouse model

Selective Laser Trabeculoplasty: 12 Years Follow Up

A New Quantifiable Blood Retinal Barrier Breakdown Model In Mice

To View More...

You must be signed into an individual account to use this feature.